Unpacking the Latest Options Trading Trends in Eli Lilly and Co
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
Financial giants have made a conspicuous bullish move on Eli Lilly and Co. Our analysis of options history for Eli Lilly and Co (NYSE:LLY) revealed 56 unusual trades.
金融巨头对礼来股票采取了显著的看好举动。我们对Eli Lilly and Co (NYSE:LLY)的期权历史进行了分析，发现有56笔飞凡的交易。
Delving into the details, we found 41% of traders were bullish, while 35% showed bearish tendencies. Out of all the trades we spotted, 10 were puts, with a value of $1,737,333, and 46 were calls, valued at $3,169,813.
进一步了解后，我们发现41%的交易员看好，而35%的交易员表现出了看淡的趋势。我们发现了10个看跌期权交易，价值为1,737,333美元，还有46个看涨期权交易，价值为3,169,813美元。
Projected Price Targets
预计价格目标
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $300.0 and $1100.0 for Eli Lilly and Co, spanning the last three months.
通过评估成交量和未平仓量，显然市场主要交易者正在关注Eli Lilly and Co在目标价区间（$300.0至$1100.0）内的表现，区间跨越了最近三个月。
Analyzing Volume & Open Interest
分析成交量和未平仓合约
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
这些数据可以帮助您跟踪Coinbase Glb期权的流动性和利益，以给定的行权价格为基础。
This data can help you track the liquidity and interest for Eli Lilly and Co's options for a given strike price.
这些数据可以帮助您追踪礼来股票在给定行权价格的期权的流动性和利益。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly and Co's whale activity within a strike price range from $300.0 to $1100.0 in the last 30 days.
以下是过去30天礼来公司所有的鲸鱼活动中，行权价格在$300.0至$1100.0区间内看涨期权和看跌期权的成交量和未平仓量的演变。
Eli Lilly and Co Option Activity Analysis: Last 30 Days
礼来 期权活动分析：过去30天
Significant Options Trades Detected:
检测到重大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | PUT | TRADE | BULLISH | 11/15/24 | $77.25 | $76.1 | $76.1 | $960.00 | $1.1M | 0 | 0 |
| LLY | CALL | TRADE | BEARISH | 01/16/26 | $202.9 | $199.05 | $199.05 | $860.00 | $199.0K | 55 | 0 |
| LLY | CALL | SWEEP | BULLISH | 01/17/25 | $63.6 | $61.4 | $62.72 | $1000.00 | $157.5K | 2.0K | 2 |
| LLY | CALL | TRADE | BULLISH | 01/17/25 | $63.55 | $61.45 | $62.83 | $1000.00 | $157.0K | 2.0K | 2 |
| LLY | CALL | TRADE | NEUTRAL | 01/17/25 | $63.4 | $60.75 | $61.86 | $1000.00 | $154.6K | 2.0K | 111 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | 看跌 | 交易 | 看好 | 11/15/24 | $77.25 | $76.1 | $76.1 | $960.00 | $1.1M | 0 | 0 |
| LLY | 看涨 | 交易 | 看淡 | 01/16/26 | $202.9 | $199.05 | $199.05 | $860.00 | $199.0K | 55 | 0 |
| LLY | 看涨 | SWEEP | 看好 | 01/17/25 | 63.6美元 | $61.4 | $62.72 | $1000.00 | $157.5K | 2.0K | 2 |
| LLY | 看涨 | 交易 | 看好 | 01/17/25 | $63.55 | $61.45 | $62.83 | $1000.00 | $157.0K | 2.0K | 2 |
| LLY | 看涨 | 交易 | 中立 | 01/17/25 | $63.4 | $60.75 | $61.86 | $1000.00 | $154.6K | 2.0K | 111 |
About Eli Lilly and Co
关于礼来
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
礼来是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。礼来的主要产品包括用于癌症的维津尼奥；马天尼罗、泽普邦、贾达信、特鲁利康、胰岛素诺和人用胰岛素用于糖尿病；以及用于免疫学的塔吉特和优泰乐。
Eli Lilly and Co's Current Market Status
礼来当前的市场状态币
- Currently trading with a volume of 915,725, the LLY's price is up by 0.76%, now at $924.94.
- RSI readings suggest the stock is currently may be overbought.
- Anticipated earnings release is in 28 days.
- 目前交易量为915,725股，LLY的价格上涨0.76%，报924.94美元。
- RSI读数表明股票目前可能超买。
- 预期财报发布在28天后。
Professional Analyst Ratings for Eli Lilly and Co
礼来的专业分析师评级
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $911.0.
过去30天中，一共有5位专业分析师对这只股票发表了评论，平均目标价为911.0美元。
- An analyst from Jefferies persists with their Buy rating on Eli Lilly and Co, maintaining a target price of $1015.
- In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $885.
- An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $885.
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $885.
- Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $885.
- Jefferies的一位分析师持续对礼来进行买入评级，维持目标价为1015美元。
- Cantor Fitzgerald的一位分析师采取谨慎的步态，将评级下调至轻仓，设定价格目标为885美元。
- Cantor Fitzgerald的一位分析师已经将其评级下调为超配，将目标价调整为885美元。
- Cantor Fitzgerald的一位分析师将其评级下调为超配，目标价为885美元。
- 反映担忧，Cantor Fitzgerald的一位分析师将评级调降至轻仓，并设定新的价格目标为885美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期权与仅交易股票相比是一种更具风险的资产，但它们具有更高的利润潜力。认真的期权交易者通过每日学习，进出交易，跟随多个指标并密切关注市场来管理这种风险。